Not sure where you get that info from. Here’s a reminder of what they have sold over the last 12 months in the last 4C, and the nice lump of cash they made from the sales of scenesse.
https://www.asx.com.au/asxpdf/20190731/pdf/4471frk3my38mn.pdf
News: CUV Clinuvel says U.S. pricing of rare disorder drug will not top European levels, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.83 |
Change
0.240(1.64%) |
Mkt cap ! $739.1M | |||
| Open | High | Low | Value | Volume |
| $14.76 | $14.96 | $14.46 | $977.6K | 66.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8 | $14.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.83 | 15 | 1 |
View Market Depth
| Last trade - 15.35pm 31/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |